Ophir Asset Management Pty LTD Trans Medics Group, Inc. Transaction History

Ophir Asset Management Pty LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$36.74 - $81.08 $4.46 Million - $9.84 Million	-121,354 Reduced 41.03%	174,407 $13.8 Million
Q3 2023 Nov 14, 2023	SELL	$53.47 - $96.07 $6.56 Million - $11.8 Million	-122,605 Reduced 29.31%	295,761 $16.2 Million
Q2 2023 Aug 11, 2023	BUY	$66.23 - $88.73 $11.5 Million - $15.3 Million	172,949 Added 70.47%	418,366 $35.1 Million
Q1 2023 May 15, 2023	SELL	$53.63 - $82.33 $13.8 Million - $21.1 Million	-256,809 Reduced 51.13%	245,417 $18.6 Million
Q4 2022 Feb 14, 2023	BUY	$39.08 - $64.29 $4.79 Million - $7.88 Million	122,634 Added 32.31%	502,226 $31 Million
Q3 2022 Nov 14, 2022	BUY	$31.56 - $55.75 $12 Million - $21.2 Million	379,592 New	379,592 $15.8 Million

388

31.4M

465K

286K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.31B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Ophir Asset Management Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Ophir Asset Management Pty LTD with notifications on news.